Blind Experiment

Treatment with delgocitinib cream leads to improvement in health-related quality of life in patients with moderate to severe chronic hand eczema, according to a phase 2b trial.

Add-on treatment may, however, benefit patients with less advanced liver disease.

A new study suggests that high doses of vitamin D supplements could help reduce disease activity among multiple sclerosis patients. Experts weigh in on the findings.

In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended remissions and protection against PsA relative to other biologics.

No survival benefit in CRPC when added to chemo; experts divided about need for more studies

Pilot study suggests dermatology tool might give early warning of when to stop dosing

/PRNewswire-PRWeb/ -- Food allergy treatment with omalizumab resulted in better outcomes with fewer adverse effects than oral immunotherapy according to new...

The OCEANIC-AF trial has raised concerns about factor XI inhibitors. Should physicians still bet on this class of anticoagulants?

After successful phase II results, a phase III study falls flat

Median PFS in MSI-H/dMMR tumors improved by more than a year with nivolumab plus ipilimumab

Spravato is now cleared to use by itself after years of clinical trials.

The key processes of skin aging are now being understood in sufficient detail that targeted prescription therapies for preventing wrinkles have reached the testing phase.

A new class of over-the-counter probiotic supplements claim to prevent hangovers by reducing gut acetaldehyde. Some scientists are skeptical.

A new guideline recommends prescribing metformin when initiating an antipsychotic to help mitigate weight gain in certain instances.

Study was stopped early due to enrollment issues, but lessons can still be learned

InterRhythmic care may help improve depressive and anxiety symptoms, interpersonal problems, and social function in patients with major depressive disorder.

When managing complex chronic dermatologic diseases, efforts to incorporate alternative treatments can add efficacy, patient reassurance, and patient engagement.

Inulin-propionate ester wasn't more effective than inulin in preventing weight gain over 12 months in young adults at risk for obesity, showed a clinical trial of the fiber-mimicking compound.

The GLP-1 receptor agonist improved both histology and fibrosis in patients, with additional improvements in their liver enzymes, noninvasive fibrosis markers, and cardiometabolic measurements.

Phase 2 data show nilotinib, a drug used to treat leukemia, improved biomarkers and cognitive outcomes in Lewy body dementia.